The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Methyldopa
Methyldopa · METHYLDOPA 500 mg/1 · Tablet, Film Coated · Oral · Chartwell RX, LLC
NDC 62135-0322-18 · 180 TABLET, FILM COATED in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,800.00
Reported to Texas DSHS · 2026 annual filing · Chartwell RX, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA018934
- TE code
- —
- Approval date
- Jun 29, 1984
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Methyldopa (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Chartwell RX, LLC | METHYLDOPA 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | METHYLDOPA 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Methyldopa — NDC 62135-0322-18," retrieved September 3, 2026, https://drugdashboards.com/drug/62135032218.
Free to cite with attribution — see how the data is put together.